Gabapentin

Product NDC: 50228-178
11-digit product format: 502280178
Labeler code: 50228
Product ID: 50228-178_176515ec-fdba-417a-b849-86aea6fd7857
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: TABLET
Route: ORAL
Labeler: ScieGen Pharmaceuticals, Inc.
Application: ANDA205101
Marketing category: ANDA
Marketing start: 2016-02-04
Substance: GABAPENTIN
Active strength: 800 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A205101-001	GABAPENTIN	GABAPENTIN	600MG	TABLET / ORAL	AB1		2016-02-04
A205101-002	GABAPENTIN	GABAPENTIN	800MG	TABLET / ORAL	AB1		2016-02-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A205101-001	AB1
A205101-002	AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2016-02-04	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2016-02-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2016-02-04	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2016-02-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2016-02-04	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2016-02-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2016-02-04	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2016-02-04	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2016-02-04	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2016-02-04	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A205101-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2016-02-04	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A205101-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2016-02-04	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A205101-001	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205101-002	AB1	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A205101-001	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205101-002	AB1	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205101-001	AB1	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205101-002	AB1	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A205101-001	AB1	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205101-002	AB1	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205101-001	AB1	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205101-002	AB1	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205101-001	AB1	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205101-002	AB1	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205101-001	AB1	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205101-002	AB1	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205101-001	AB1	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205101-002	AB1	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205101-001	AB1	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205101-002	AB1	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205101-001	AB1	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205101-002	AB1	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A205101-001	AB1	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A205101-002	AB1	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205101-001	AB1	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205101-002	AB1	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205101-001	AB1	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205101-002	AB1	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A205101-001	AB1	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A205101-002	AB1	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A205101-001	AB1	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A205101-002	AB1	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A205101-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A205101-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A205101-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A205101-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A205101-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A205101-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A205101-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A205101-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A205101-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A205101-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Gabapentin
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	800 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310433	Internal RxNorm lookup
310434	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50228-178-01	Gabapentin	100 in 1 BOTTLE	TABLET	100	17
50228-178-05	Gabapentin	500 in 1 BOTTLE	TABLET	500	17
50228-178-30	Gabapentin	30 in 1 BOTTLE	TABLET	30	17

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50228-178-01	EA - Each	50228-178	d44c08b6-3ef7-4975-836a-f416c8230a63	1	2019-02-13
50228-178-05	EA - Each	50228-178	b4947673-f259-4815-9257-32179b9722b7	1	2019-02-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50228-178	GABAPENTIN TABLET [SCIEGEN PHARMACEUTICALS, INC.]	13	Current NDC, Legacy NDC, 3 package rows	20241109_5ab9c18b-9568-4dcb-90b0-252aef8f8dc2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 31 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	PD-Rx Pharmaceuticals, Inc.	9b175f8d-7667-4bfe-8bb5-fd7441eed456	2026-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	HAWAII REPACK, INC.	f6ff265b-569b-4f5c-8fdb-00b7ad4aac7c	2026-07-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	ba4d863d-be38-8cf5-e053-2995a90a69fb	2026-06-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	St. Mary's Medical Park Pharmacy	c85ae572-9893-629e-e053-2995a90a23fc	2026-06-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	ce0f0d7f-da6d-47da-a4ed-fb8f72902412	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	abb56036-88df-4720-ba78-529971671545	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	a75c9157-a1fc-44cc-89f8-c5a3742fb9ed	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	d1aa4690-57b5-4a3e-ac12-85f777dbd05e	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	75caca13-1432-4c0d-8d45-f029b0b2d417	2026-03-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	56378630-e7a7-4981-8212-8ea703a433d8	2026-03-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Radha Pharmaceuticals, Inc.	1045db4e-4c76-4a0d-bf12-019bd96a8f59	2026-03-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	ScieGen Pharmaceuticals, Inc.	5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	2026-02-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101 ndc (product): 50228-178
Gabapentin	GABAPENTIN	Preferred Pharmaceuticals, Inc.	5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151	2025-06-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Preferred Pharmaceuticals, Inc.	561f53d5-5301-42b3-b372-f3d49d642a2e	2025-06-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Coupler LLC	3133fc78-dd7a-880c-e063-6394a90a89e1	2025-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Directrx	d5c9dd2c-b8ee-1406-e053-2995a90a0287	2025-01-21	Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
GABAPENTIN	GABAPENTIN	DIRECT RX	a7e45e3f-e382-32ba-e053-2a95a90a2537	2025-01-17		Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	Creekwood Pharmaceuticals LLC	266ef369-0a56-f225-e063-6294a90a495e	2024-09-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	NuCare Pharmaceuticals,Inc.	a9c99dfa-f54d-9207-e053-2995a90ad43b	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101
Gabapentin	GABAPENTIN	NuCare Pharmaceuticals,Inc.	a9f0852e-0c58-ba22-e053-2995a90adfa0	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 205101 application number: ANDA205101

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310434	gabapentin 800 MG Oral Tablet	PSN	d1aa4690-57b5-4a3e-ac12-85f777dbd05e	105
310434	gabapentin 800 MG Oral Tablet	PSN	a75c9157-a1fc-44cc-89f8-c5a3742fb9ed	105
310434	gabapentin 800 MG Oral Tablet	SCD	d1aa4690-57b5-4a3e-ac12-85f777dbd05e	105
310434	gabapentin 800 MG Oral Tablet	SCD	a75c9157-a1fc-44cc-89f8-c5a3742fb9ed	105
310434	gabapentin 800 MG Oral Tablet	PSN	75caca13-1432-4c0d-8d45-f029b0b2d417	101
310434	gabapentin 800 MG Oral Tablet	SCD	75caca13-1432-4c0d-8d45-f029b0b2d417	101
310433	gabapentin 600 MG Oral Tablet	PSN	5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	17
310434	gabapentin 800 MG Oral Tablet	PSN	5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	17
310433	gabapentin 600 MG Oral Tablet	SCD	5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	17
310434	gabapentin 800 MG Oral Tablet	SCD	5ab9c18b-9568-4dcb-90b0-252aef8f8dc2	17
310430	gabapentin 100 MG Oral Capsule	PSN	a7e45e3f-e382-32ba-e053-2a95a90a2537	15
310432	gabapentin 400 MG Oral Capsule	PSN	a7e45e3f-e382-32ba-e053-2a95a90a2537	15
310434	gabapentin 800 MG Oral Tablet	PSN	9b175f8d-7667-4bfe-8bb5-fd7441eed456	15
310434	gabapentin 800 MG Oral Tablet	PSN	a7e45e3f-e382-32ba-e053-2a95a90a2537	15
310430	gabapentin 100 MG Oral Capsule	SCD	a7e45e3f-e382-32ba-e053-2a95a90a2537	15
310432	gabapentin 400 MG Oral Capsule	SCD	a7e45e3f-e382-32ba-e053-2a95a90a2537	15
310434	gabapentin 800 MG Oral Tablet	SCD	9b175f8d-7667-4bfe-8bb5-fd7441eed456	15
310434	gabapentin 800 MG Oral Tablet	SCD	a7e45e3f-e382-32ba-e053-2a95a90a2537	15
310434	gabapentin 800 MG Oral Tablet	PSN	5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151	6
310434	gabapentin 800 MG Oral Tablet	PSN	561f53d5-5301-42b3-b372-f3d49d642a2e	6
310434	gabapentin 800 MG Oral Tablet	SCD	5d3f27bf-3486-40fa-a4d3-5f0b2c6c0151	6
310434	gabapentin 800 MG Oral Tablet	SCD	561f53d5-5301-42b3-b372-f3d49d642a2e	6
310434	gabapentin 800 MG Oral Tablet	PSN	a8a533f9-59f1-4227-a16b-3f616f1b8bbd	4
310434	gabapentin 800 MG Oral Tablet	SCD	a8a533f9-59f1-4227-a16b-3f616f1b8bbd	4
310434	gabapentin 800 MG Oral Tablet	PSN	f1bce199-9f88-4a94-9006-8e148dedd45f	3
310434	gabapentin 800 MG Oral Tablet	PSN	a9f0852e-0c58-ba22-e053-2995a90adfa0	3
310434	gabapentin 800 MG Oral Tablet	PSN	a9c99dfa-f54d-9207-e053-2995a90ad43b	3
310434	gabapentin 800 MG Oral Tablet	PSN	c85ae572-9893-629e-e053-2995a90a23fc	3
310434	gabapentin 800 MG Oral Tablet	SCD	a9c99dfa-f54d-9207-e053-2995a90ad43b	3
310434	gabapentin 800 MG Oral Tablet	SCD	a9f0852e-0c58-ba22-e053-2995a90adfa0	3
310434	gabapentin 800 MG Oral Tablet	SCD	c85ae572-9893-629e-e053-2995a90a23fc	3
310434	gabapentin 800 MG Oral Tablet	SCD	f1bce199-9f88-4a94-9006-8e148dedd45f	3
310434	gabapentin 800 MG Oral Tablet	PSN	2b76955c-52a4-4026-b286-3da1112fe989	2
310434	gabapentin 800 MG Oral Tablet	SCD	2b76955c-52a4-4026-b286-3da1112fe989	2
310434	gabapentin 800 MG Oral Tablet	PSN	9d544944-ea95-42e1-8c65-9e442437f0ee	1
310434	gabapentin 800 MG Oral Tablet	PSN	af62bb7e-162e-4e2a-8eb0-d50f66678707	1
310434	gabapentin 800 MG Oral Tablet	PSN	3133fc78-dd7a-880c-e063-6394a90a89e1	1
310434	gabapentin 800 MG Oral Tablet	SCD	9d544944-ea95-42e1-8c65-9e442437f0ee	1
310434	gabapentin 800 MG Oral Tablet	SCD	af62bb7e-162e-4e2a-8eb0-d50f66678707	1
310434	gabapentin 800 MG Oral Tablet	SCD	3133fc78-dd7a-880c-e063-6394a90a89e1	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50228-178-01	50228017801	100 TABLET in 1 BOTTLE (50228-178-01)	100 tablet	2018-08-20	0000-00-00	No	No	Current
50228-178-05	50228017805	500 TABLET in 1 BOTTLE (50228-178-05)	500 tablet	2016-02-04	0000-00-00	No	No	Current
50228-178-30	50228017830	30 TABLET in 1 BOTTLE (50228-178-30)	30 tablet	2016-02-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Gabapentin	PD-Rx Pharmaceuticals, Inc.	2026-07-08	HUMAN PRESCRIPTION DRUG LABEL	16
Gabapentin	HAWAII REPACK, INC.	2026-07-02	HUMAN PRESCRIPTION DRUG LABEL	1
Gabapentin	St. Mary's Medical Park Pharmacy	2026-06-26	HUMAN PRESCRIPTION DRUG LABEL	4
Gabapentin	Bryant Ranch Prepack	2026-04-13	HUMAN PRESCRIPTION DRUG LABEL	105
Gabapentin	Bryant Ranch Prepack	2026-04-13	HUMAN PRESCRIPTION DRUG LABEL	105
Gabapentin	Bryant Ranch Prepack	2026-03-31	HUMAN PRESCRIPTION DRUG LABEL	101
Gabapentin	ScieGen Pharmaceuticals, Inc.	2026-02-20	HUMAN PRESCRIPTION DRUG LABEL	17
Gabapentin	Preferred Pharmaceuticals, Inc.	2025-06-11	HUMAN PRESCRIPTION DRUG LABEL	6
Gabapentin	Preferred Pharmaceuticals, Inc.	2025-06-11	HUMAN PRESCRIPTION DRUG LABEL	6
Gabapentin	Coupler LLC	2025-03-25	HUMAN PRESCRIPTION DRUG LABEL	1
GABAPENTIN	DIRECT RX	2025-01-17	HUMAN PRESCRIPTION DRUG LABEL	15
Gabapentin	NuCare Pharmaceuticals,Inc.	2024-07-17	HUMAN PRESCRIPTION DRUG LABEL	3
Gabapentin	NuCare Pharmaceuticals,Inc.	2024-07-17	HUMAN PRESCRIPTION DRUG LABEL	3
Gabapentin	REMEDYREPACK INC.	2024-03-06	HUMAN PRESCRIPTION DRUG LABEL	6
Gabapentin	Aphena Pharma Solutions - Tennessee, LLC	2023-09-22	HUMAN PRESCRIPTION DRUG LABEL	1
Gabapentin	Asclemed USA, Inc. \| ASCLEMED USA INC. DBA ENOVACHEM	2022-10-10	HUMAN PRESCRIPTION DRUG LABEL	1
Gabapentin	Proficient Rx LP	2022-04-01	HUMAN PRESCRIPTION DRUG LABEL	2
Gabapentin	Aphena Pharma Solutions - Tennessee, LLC	2021-12-08	HUMAN PRESCRIPTION DRUG LABEL	4
Gabapentin	A-S Medication Solutions	2021-04-15	HUMAN PRESCRIPTION DRUG LABEL	3